Check out their newly launched version….lots of information that you might find useful.
Category: Ovarian
Prospective Lynch syndrome database
A prospective Lynch syndrome database is important because it allows researchers, clinicians, and policymakers to collect and analyse long-term, standardised data on people with Lynch syndrome (LS).
(Using Chat GPT)
📌 In short: A prospective Lynch syndrome database is essential because it produces high-quality, unbiased evidence on cancer risks, surveillance effectiveness, and preventive strategies, directly improving patient care and shaping clinical guidelines.
Here are the key reasons why it matters, based only on reliable clinical and research perspectives:
- Natural history understanding
- Prospective data (collected forward in time) helps clarify the true risks of different cancers (colorectal, endometrial, ovarian, gastric, etc.) in Lynch syndrome carriers.
- It reduces biases compared to retrospective reports, which often overestimate risks due to selective reporting of severe cases.
- Better risk stratification
- Different mismatch repair (MMR) gene variants (MLH1, MSH2, MSH6, PMS2, EPCAM) carry different cancer risks.
- A prospective database helps define more precise, gene-specific and even sex-specific risk estimates, which guide personalized surveillance.
- Evaluation of surveillance effectiveness
- Prospective registries allow direct measurement of how colonoscopy intervals (e.g., every 1–2 years) affect cancer incidence, stage at diagnosis, and mortality.
- They can test whether surveillance reduces advanced cancers, enabling evidence-based guideline updates.
- Assessment of preventive strategies
- Allows evaluation of risk-reducing interventions such as aspirin (e.g., CAPP2/CAPP3 trials), prophylactic surgeries, or lifestyle modifications.
- Can help identify who benefits most from preventive measures.
- Improved clinical counseling
- Physicians and genetic counselors can give patients more reliable, individualized risk information, reducing uncertainty and supporting informed decisions.
- Data for health policy
- National or international databases provide evidence for cost-effectiveness of surveillance and preventive programs.
- This supports resource allocation and insurance coverage for Lynch syndrome management.
- Research opportunities
- Creates a resource for studying modifiers of cancer risk (genetic, environmental, lifestyle).
- Enables collaboration across centers and countries for rare cancers within LS populations.
Preventing Ovarian Cancer: Living With Consequences
Key Takeaways:
- Lynch syndrome can necessitate early oophorectomy, leading to abrupt surgical menopause and significant health impacts due to sudden estrogen loss.
- Estrogen plays a crucial role in protecting bones, joints, brain, heart, and emotional well-being, with its absence exacerbating conditions like osteoarthritis and cardiovascular disease.
- The narrative calls for broader menopause discussions, including the experiences of women undergoing early surgical menopause, and emphasizes the need for more research and nuanced care.
- The author stresses the importance of managing chronic conditions and mental health post-surgery, advocating for better support and understanding for women facing similar challenges.
A Beginner’s Guide to Lynch Syndrome
Lynch Syndrome(www.thisisgo.ie)
Oncologist explains the subtle signs of ‘silent killer’ ovarian cancer
Each year in Ireland, over 600 new cases of ovarian cancer are diagnosed and around 400 women die from this type of cancer annually.
There’s still a lot of misconceptions about ovarian cancer, such as women mistakenly believing cervical screening will prevent or detect it – it doesn’t. This is why it’s so important for women to be aware of the symptoms of ovarian cancer, and to not ignore them.
Remember the most common symptoms: BEAT, which stands for:
- Bloating that doesn’t go away
- Eating and feeling fuller earlier
- Abdominal or pelvic pain
- Toilet – changes to your toilet habits that are new (passing urine or bowel issues)
Check out: http://www.ovacare.ie + http://www.thisisgo.ie
The Myth that Cervical Screening Checks for All Gynecological Cancers
Research in Ireland commissioned by the Irish Network of Gynaecological Oncology (INGO) and supported by Breakthrough Cancer Research highlights the misconceptions that exist surrounding cervical screening, showing that one in three women in Ireland (34%) mistakenly believe that cervical screening checks for all five gynecological cancers
(https://isgo.ie/ingo-outputs/).
Supporting patient pathway though gynaecological cancer
Women themselves may be unaware of the sometimes symptoms or may be too embarrassed to consult a doctor, and there remains a stigma associated with these diagnoses in some quarters. This reticence needs to be overcome and a more positive message developed to improve the prevention, screening, treatment and care of gynaecological cancers so that women throughout Europe have the best chance of survival and quality of life.
Ovarian, uterine, cervix and other gynaecological cancers are among the most common cancers to affect women, but collectively attract less attention than they deserve from the public and policy makers.
WHAT SHOULD YOU ASK THE DOCTOR?
Useful information before, during, and after your meeting with your doctor(s)
Brochure from ENGAGe (The European Network of Gynaecological Cancer Advocacy Groups is an ESGO network of European patient advocacy groups representing all gynaecological cancers)
https://engage.esgo.org/brochures/what-should-you-ask-the-doctor/
Recent Advances in Lynch Syndrome Diagnosis, Treatment and Cancer Prevention
Conclusion:
The identification and management of individuals and families with Lynch syndrome has evolved rapidly during the past decade or so. Advances in molecular testing and NGS technologies now allow all patients with colorectal and endometrial cancers to reliably receive screening for underlying Lynch syndrome, whereas innovations in immuno-oncology promise to continue revolutionising the treatment of Lynch-associated cancers.
To continue moving the needle forward, expanded efforts to diagnose Lynch syndrome in healthy, cancer-free individuals are needed, rather than relying on the identification of Lynch syndrome through a new cancer diagnosis.
Identification of Lynch syndrome offers the potential to prevent cancer-related morbidity and mortality, and continued progress in understanding the immune system’s ability to recognize, eradicate, and intercept Lynch-associated neoplasia offers many intriguing possibilities for immune-based primary cancer prevention.
Menopause, Diet and Cancer
This resource is designed to offer practical, evidence-based guidance on how dietary and lifestyle choices can alleviate menopausal symptoms and enhance overall well-being during this unique phase of life. Cancer treatments can sometimes trigger a sudden, intense menopause, often leading to more severe symptoms than those of natural menopause. For some, these symptoms are manageable, while others may find them overwhelming, impacting quality of life.
This book provides support and strategies, covering nutrition and lifestyle modifications to help ease these challenges.
Lynch Syndrome Ireland 